🔎 Trials Near Me

Hjem › Amyloidose › Tennessee

Amyloidose kliniske forsøg i Tennessee

7 studier for Amyloidose søger deltagere på steder i Tennessee.

Byer i Tennessee

Officiel studietekst (engelsk)

Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis

  • Research Site, Germantown
  • Research Site, Nashville
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 23. sep. 2026 · NCT06465810

TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy

  • Clinical Trial Site, Nashville
RekruttererFase 3
Alder 18 til 85 · Alle køn · Opdateret 15. sep. 2026 · NCT07223203

DemonsTTRate: A Global, Observational, Multicenter, Long-term Study of Patients With ATTR-CM in a Real-World Setting

  • Clinical Trial Site, Memphis
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 9. sep. 2026 · NCT07358078

Phase 1/2a Study of Belantamab Mafodotin in Relapsed or Refractory AL Amyloidosis

  • Vanderbilt Ingram Cancer Center, Nashville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 19. aug. 2026 · NCT05145816

A Phase 1 Study of 99mTc-p5+14 in Healthy Volunteers and Patients With AL or ATTR Systemic Amyloidosis

  • University of Tennessee Graduate School of Medicine, Knoxville
RekruttererFase 1Frivillige med god helbredstilstand velkomne
Alder 18 og opefter · Alle køn · Opdateret 24. jul. 2026 · NCT05951816

A Phase 1b/2 Study of CAR T Cell Therapy Targeting CD19 and BCMA in Participants With Relapsed or Refractory AL Amyloidosis.

  • Research Site, Nashville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 2. jul. 2026 · NCT07081646

A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion

  • Vanderbilt University Medical Center. /ID# 273510, Nashville
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 13. maj 2026 · NCT06158854

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.